August 15, 2026 05:50 pm (IST)
Follow us:
Genpact appoints Hanspeter Spek as Director
New York, Apr 3 (IBNS): Business process management company Genpact Limited on Thursday announced Hanspeter Spek as a member of its Board of Directors.
“We are honored to have Hanspeter join the Genpact Board. With his extensive global experience, he will bring significant value to Genpact and its Board,” said Robert Scott, Chairman of the Board, Genpact.
Spek, who also currently serves as Chairman of the Board of Sanofi Germany, spent his career in the pharmaceutical industry where he most recently served as president of Global Operations at Sanofi S.A. before retiring in June 2013.
Beginning his career at Pfizer, where he spent more than 10 years in increasingly responsible product and marketing management roles,Spek then joined Sanofi in 1985.
His tenure there spanned a number of senior management roles including senior vice president of Europe following the merger with Synthélabo in 1999, director of Worldwide Operations of Sanofi-Synthélabo, and executive vice president of Global Pharmaceutical Operations for Sanofi-Aventis before he was promoted to president of Global Operations in 2009.
A native of Germany, he currently resides in Paris.
“Genpact is thrilled to add another outstanding business leader to our Board. Hanspeter, who has had such a long and distinguished career in the pharmaceutical and life sciences industry, will bring great insights in one of our core focus industries,” said NV ‘Tiger’ Tyagarajan, president and CEO, Genpact.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Emami’s big snack bet: ₹750 crore investment, new WeMe brand targets ₹1,000 crore in 3-5 years
Sat, Aug 15 2026
HCG Q1 results: Cancer care major posts 190% jump in adjusted profit, revenue rises 13%
Fri, Aug 14 2026
Big relief for Zee Entertainment: SAT allows warrants issue, dividend access despite SEBI ban
Fri, Aug 14 2026
Olectra Greentech Q1 shocker: Revenue soars 66%, profit barely moves; shares crash 4%
Fri, Aug 14 2026
Red Friday on Dalal Street: Sensex plunges 300 points, Nifty slides amid geopolitical tensions
Fri, Aug 14 2026
Tata Motors shares jump 6% after Q1 profit soars 83% to ₹2,560 crore
Thu, Aug 13 2026
RVNL posts strong Q1 numbers, but shares fall sharply
Thu, Aug 13 2026
Profit soars 39%, but Grasim stock crashes 3% after Q1 results
Thu, Aug 13 2026